Lilly depression drug fails late-stage trial

(Reuters) - Eli Lilly and Co on Thursday said its experimental drug to treat major depression failed to meet it primary goal in three late-stage trials and the drugmaker will not seek approval of the medicine for that condition.

via Reuters: Health News Read More Here..